Subscribe
shutterstock_1642888921_kira_yan
Kira Yan / Shutterstock.com
1 September 2020Big PharmaMuireann Bolger

European Commission's first deal for COVID-19 vaccine takes effect

The  European Commission’s first ever contract to secure a COVID-19 vaccine came into force on August 27, after it signed a deal with pharmaceutical company  AstraZeneca earlier this month.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Europe
EC reveals plans for unitary SPC, compulsory licences
8 February 2022   The European Commission will unveil plans to make supplementary protection certificates more accessible and efficient for pharmaceutical companies to register and enforce by the end of March.
Big Pharma
EU reaches first COVID-19 vaccine deal
17 August 2020   The European Commission reached its first agreement to supply EU member states with an experimental COVID-19 vaccine with AstraZeneca late last week.
Americas
Associations lobby WHO to build COVID-19 IP pool
31 March 2020   Numerous associations and individuals have come together to ask the World Health Organization to build a global pool for IP rights related to the COVID-19 pandemic.


Editor's picks

UKIPO rejects Boehringer’s SPC for horse inhaler
Europe
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025

Editor's picks

Europe
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025
Americas
Bankruptcy judge approves $305m sale of genetics testing company
1 July 2025
Americas
A step too far? Why Stewart’s approach is dividing opinion
24 June 2025
Europe
Diverging in the detail: UPC local divisions and Court of Appeal take different paths
19 June 2025
Europe
UPC confirms permanent injunction against Curio in 10x tech dispute
17 June 2025
Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025

More on this story

Europe
EC reveals plans for unitary SPC, compulsory licences
8 February 2022   The European Commission will unveil plans to make supplementary protection certificates more accessible and efficient for pharmaceutical companies to register and enforce by the end of March.
Big Pharma
EU reaches first COVID-19 vaccine deal
17 August 2020   The European Commission reached its first agreement to supply EU member states with an experimental COVID-19 vaccine with AstraZeneca late last week.
Americas
Associations lobby WHO to build COVID-19 IP pool
31 March 2020   Numerous associations and individuals have come together to ask the World Health Organization to build a global pool for IP rights related to the COVID-19 pandemic.

More on this story

Europe
EC reveals plans for unitary SPC, compulsory licences
8 February 2022   The European Commission will unveil plans to make supplementary protection certificates more accessible and efficient for pharmaceutical companies to register and enforce by the end of March.
Big Pharma
EU reaches first COVID-19 vaccine deal
17 August 2020   The European Commission reached its first agreement to supply EU member states with an experimental COVID-19 vaccine with AstraZeneca late last week.
Americas
Associations lobby WHO to build COVID-19 IP pool
31 March 2020   Numerous associations and individuals have come together to ask the World Health Organization to build a global pool for IP rights related to the COVID-19 pandemic.

More features

WATCH: The transparency tightrope—balancing innovation, regulation, and IP protection in a new era
Chicago firm Much Shelist adds partner with ‘entrepreneurial mindset’
Powell Gilbert launches Düsseldorf office with leading patent litigator
Startups toolkit: Why investors want more than patents
J&J fends off generic schizophrenia drug bids
Kilpatrick adds ‘seasoned litigator’ as trademark partner
WATCH: An update on EPO Board of Appeal strategy for 2025 and beyond
Startup challenges rival over brain monitoring tech at ITC